TTop stories Read More Philips agrees to acquire SpectraWAVE Inc.December 15, 2025 Sources [1] The SpectraWAVE HyperVue Imaging System and the Starlight Imaging Catheter is a US Class 2…
HHeadlines Read More Stanford Medicine study shows why mRNA-based COVID-19 vaccines can cause myocarditisDecember 10, 2025 “Two proteins, named CXCL10 and IFN-gamma, popped up. We think these two are the major drivers of myocarditis,”…
HHeadlines Read More A disproportionality analysis of real-world adverse events associated with tirofiban from the FAERS databaseSeptember 1, 2025 Tirofiban, as a GP IIb/IIIa receptor antagonist, competitively inhibits the bridging of platelets via fibrin, which is the…
HHeadlines Read More Philips FHI 2025 Cardiology SnapshotAugust 26, 2025 Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and…
HHeadlines Read More Association between C-reactive protein-triglyceride glucose index and Future cardiovascular disease risk in a population with cardiovascular-Kidney-metabolic syndrome stage 0–3August 24, 2025 This study is the first to investigate the relationship between the CTI and CVD risk among individuals with…
HHeadlines Read More Phase 3 Trial Confirms Sarilumab Improves Polymyalgia Rheumatica OutcomesAugust 15, 2025 Vibeke Strand, MD Credit: PRIME Education New phase 3 data supported the effectiveness of sarilumab 200 mg every…